The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Funding & IP Licensing Updates

23 Dec 2009 07:01

RNS Number : 6007E
Amphion Innovations PLC
23 December 2009
 



Amphion Innovations plc Funding Update and  Signs Eight License Agreements worth $4.15 million

 

London and New York, 23 December 2009 - Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of medical and technology businesses, today announces that it has received a further subscription of £1,100,000 for the Convertible Promissory Note, first announced on 31 December 2008. This brings the total amount issued to £4,833,265 on the same terms as previously announced. 

Amphion also today announces that its wholly owned subsidiary DataTern, Inc., has signed additional non-exclusive intellectual property license agreements with eight leading international corporations for a total of $4.15 million.  DataTern has signed 18 licenses since it commenced licensing of this product in June 2008, generating total revenues of approximately $13 million.  DataTern has now licensed its intellectual property into the financial, credit card, insurance, retail, leisure, healthcare, airline, e-commerce, and software industries. 

DataTern, Inc., was established in order to commercialise selected intellectual property opportunities in partnership with Amphion's Partner Companies. 

Richard Morgan, CEO of Amphion said, "We are pleased to announce the continued success of our licensing programme. DataTern has signed a total of 15 agreements for approximately $7.6 million over the course of 2009 and we are optimistic we will achieve a similar level of business in the coming year."

For further information please contact 

Amphion Innovations plc Charlie Morgan, Director of Communications +1 (212) 210 6224

Cardew Group +44 20 7930 0777

Charles Stanley (Nominated Adviser Mark Taylor/ Freddy Crossley +44 20 7149 6000

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 10 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.

On the web: www.amphionplc.com 

  About DataTern, Inc.

DataTern owns and develops critical technology that provides next generation software solutions for its customers. DataTern's patented product offerings include ObjectSpark® Technologies, which allow customers to develop their own customised data service layers, making the company's offerings valuable to most industries, including automotive, banking, chemical, communications, financial, government, healthcare, insurance, pharmaceutical, trading, and many others. Non-exclusive licenses for DataTern's technologies and patents are available on reasonable and non-discriminatory terms. 

For licensing terms, please contact info@datatern.com

On the web: www.datatern.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPAAADLNFFE
Date   Source Headline
8th Jun 20067:01 amRNSAppointment
6th Jun 20067:01 amRNSRe Agreement
5th Jun 20063:16 pmRNSThe Shafallah Center
2nd Jun 20065:01 pmRNSDr David Evans
1st Jun 20067:00 amRNSAnnual Report and Accounts
23rd May 20067:00 amRNSDirector/PDMR Shareholding
22nd May 20061:41 pmRNSDirector/PDMR Shareholding
19th May 20065:12 pmRNSDirector Share Transaction
15th Mar 20069:25 amRNSCompletion of a Financing
8th Mar 20067:04 amRNSFinal Results
2nd Mar 20069:12 amRNSMotif BioSciences
27th Feb 20064:56 pmRNSNotice of Results
23rd Feb 20067:02 amRNSRe: WellGen Financing
3rd Jan 20067:01 amRNSAdditional Investments
5th Dec 200512:48 pmRNSDirector Shareholding
10th Oct 20057:00 amRNSAcquires a stake
21st Sep 20057:00 amRNSStake in Spin-Out Company
30th Aug 20057:00 amRNSAmphion Invests in WellGen
25th Aug 20054:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.